Tricaprilin is an orally active medium chain triglyceride that improves mitochondrial metabolism by inducing a ketosis state. It can be used in studies related to Alzheimer's disease (AD).
Tricaprilin is an orally active medium chain triglyceride that improves mitochondrial metabolism by inducing a ketosis state. It can be used in studies related to Alzheimer's disease (AD).
Tricarballylic acid is an inhibitor of aconitase and therefore interferes with the Krebs cycle.
Trichlormethiazide is a diuretic with properties similar to those of hydrochlorothiazide.
Trichloroacetic acid (TCA) is derived from trichloroethylene (TCE) metabolism. It can be used as an acid decalcifier. Trichloroacetic acid, a metabolite of Trichloroacetic acid, is believed to contribute to its liver cancer effect in mice.
Trichloroacetic acid (TCA) is derived from trichloroethylene (TCE) metabolism. It can be used as an acid decalcifier. Trichloroacetic acid, a metabolite of Trichloroacetic acid, is believed to contribute to its liver cancer effect in mice.
Trichostatin A (TSA) is a potent and specific inhibitor of mammalian histone deacetylase (HDAC) class I/II, with an IC50 value of 1.8 nM for HDAC.
Trichostatin A (TSA) is a potent and specific inhibitor of mammalian histone deacetylase (HDAC) class I/II, with an IC50 value of 1.8 nM for HDAC.
Trichostatin A (TSA) is a potent and specific inhibitor of mammalian histone deacetylase (HDAC) class I/II, with an IC50 value of 1.8 nM for HDAC.
Trichostatin A (TSA) is a potent and specific inhibitor of mammalian histone deacetylase (HDAC) class I/II, with an IC50 value of 1.8 nM for HDAC.